ovarian cancer. Malignant neoplasm of ovary
Conditions
Interventions
Intervention 1: Control group: Karbo platinum dose Taksl Pakly 5-6 AUC and dose of 175 mg per square meter for 6 cycles. Intervention 2: Groups: drug Karbv platinum dose 5-6 AUC and Pakly Taksl dose o
Treatment - Drugs
Control group: Karbo platinum dose Taksl Pakly 5-6 AUC and dose of 175 mg per square meter for 6 cycles
Groups: drug Karbv platinum dose 5-6 AUC and Pakly Taksl dose of 175 mg per square meter and ginger (ginger 1 g made at the that Faculty of Pharmacy, Tabriz) at a dose of 2 g daily for 6 cycles admin
Sponsors
vice chancellor of research,Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Encloses Criteria: women with ovarian cancer who had cytoreductive surgery; Wilting to participate in study Exclusion criteria: Sensitivity to ginger ; history of previous chemotherapy; history of gynecological cancer; using vit E or omega3; Intolerances to chemotherapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The results of the CT scan of the abdomen and pelvis. Timepoint: Intervals during treatment and after treatment every 3 months for one year. Method of measurement: CT scan of the abdomen and pelvis.;CA125 results in the groups receiving platinum and paclitaxel. Timepoint: Intervals during treatment and after treatment every 3 months for one year. Method of measurement: Blood tests.;Side effects. Timepoint: During treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Parvin Mostafa Gharabaghi
Tabriz University of Medical Sciences
Outcome results
None listed